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Allergic contact dermatitis ensues from exaggerated
T cell responses to haptens. Dendritic cells are
required for the initiation of hapten sensitization, but
they may not be necessary for disease expression.
Here we investigated the antigen-presenting cell
requirement of nickel-speci®c CD4+ lymphocytes
isolated from the blood of six allergic individuals. A
signi®cant proportion (42 out of 121; 35%) of the T
cell clones proliferated in vitro to nickel also in the
absence of professional antigen-presenting cells,
suggesting a direct T±T hapten presentation.
Antigen-presenting-cell-independent T cells showed
a predominant T helper 1 phenotype. Nickel recogni-
tion by these T cells was major histocompatibility
complex class II restricted, not in¯uenced by CD28
triggering, independent from their state of activation,
and did not require processing. The capacity of this T
cell subset to be directly stimulated by nickel was not
due to unique antigen-presenting properties, as both
antigen-presenting-cell-dependent and antigen-pre-
senting-cell-independent clones displayed comparable
levels of HLA-DR, CD80, and CD86, and were
equally capable of presenting nickel to antigen-pre-
senting-cell-independent clones. In contrast, neither
T cell types activated antigen-presenting-cell-depend-
ent T lymphocytes. T±T presentation induced T cell
receptor downregulation, CD25, CD80, CD86, and
HLA-DR upregulation, and interferon-g release,
although to a lesser extent compared to those induced
by dendritic cell±T presentation. Following T±T pre-
sentation, the clones did not undergo unresponsive-
ness and maintained the capacity to respond to
dendritic cells pulsed with antigen. In aggregate, our
data suggest that antigen-presenting-cell-independent
T cell activation can effectively amplify hapten-
speci®c immune responses. Key words: allergy/antigen
presentation/nickel/skin/T lymphocytes. J Invest Dermatol
118:172±179, 2002
A
llergic contact dermatitis (ACD) is a common T-cell-
dependent disease due to exaggerated immune
responses to haptens applied onto the skin (Grabbe
and Schwarz, 1998; Cavani et al, 2001). Skin
dendritic cells (DC) are essential in the development
of hapten-speci®c T cell responses. Upon hapten exposure,
maturing Langerhans cells and dermal DC migrate towards regional
lymph nodes (Kripke et al, 1990; FoÈrster et al, 1999; Rennert et al,
2001), where the hapten±peptide complexes are presented to naive
T cells in a major histocompatibility complex (MHC) restricted
manner. In sensitized individuals, hapten challenge determines the
rapid recruitment into the skin of speci®c memory T lymphocytes,
which upon activation mediate the tissue damage (Traidl et al,
2000). The role of DC in the expression phase of ACD is less
de®ned, and they may not be required. In particular, the expression
of murine contact hypersensitivity is increased when the hapten is
applied on skin depleted of Langerhans cells (Grabbe et al, 1995).
Indeed, the need for professional antigen-presenting cells (APC) in
the activation of memory/effector T lymphocytes is less stringent
compared to that of naive T cells (Dubey et al, 1996; Iezzi et al,
1998; Lanzavecchia and Sallusto, 2000). Consistent with this
notion, the effector phase of contact hypersensitivity is less
dependent on T cell costimulation than the sensitization phase
(Nuriya et al, 2001). Various skin cell types can serve as APC for
memory/effector T cells during the efferent phase of skin immune
responses, including endothelial cells, ®broblasts, and keratinocytes
(KuÈndig et al, 1995; Ma and Pober, 1998; Traidl et al, 2000).
Following in vivo or in vitro activation, human T lymphocytes
express MHC class II and costimulatory molecules, and they thus
have the potential to act as APC. It has been previously shown that
T±T presentation occurs for peptides or denatured proteins,
resulting either in functional T cell activation (Gerrard et al,
1985; Hewitt et al, 1989; LaSalle et al, 1991; Barnaba et al, 1994) or
T cell anergy (Lamb et al, 1983; Celis and Saibara, 1992; Sidhu et al,
1992; Marelli-Berg et al, 1997; Taams et al, 1999). In the case of
hapten-speci®c T cell responses, the occurrence of T±T present-
ation has not been investigated yet. In this study, we show that a
signi®cant proportion of nickel-speci®c CD4+ T cells undergo
activation when exposed to the metal in the absence of professional
APC, and may be importantly involved in the ampli®cation of
immune response to haptens.
MATERIALS AND METHODS
Patients Six non-atopic patients (median age, 28 y; three females and
three males) with ACD to nickel were enrolled in the study. Patients
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had a history of eczematous dermatitis after contacting metals and a
positive patch test to 5% NiSO4. They were not taking any medication
for at least 15 d before blood donation. Peripheral blood samples were
obtained after informed consent.
Antibodies The following mouse antihuman monoclonal antibodies
(MoAb) were used: pure anti-HLA-DP (B7/21, mIgG1), anti-HLA-DR
(G46-6, mIgG2a), and anti-CD28 (CD28.2, mIgG1), and ¯uorescein
isothiocyanate (FITC) conjugated anti-CD3 (Leu-4, mIgG1), anti-CD4
(SK3, mIgG1), anti-CD25 (2A3, mIgG1), anti-CD14 (MFP9, mIgG2a),
anti-HLA-DR (L243, mIgG2a); anti-CD1a (HI149, IgG1), anti-CD83
(Hb15a, IgG2a), anti-CD80 (L307.4, mIgG1), and anti-CD86 (2331,
mIgG1) were purchased from BD PharMingen (San Diego, CA). Pure
anti-CD3 (UCHT1, IgG1) MoAb was provided by Immunokontact
(Boggio, Switzerland). Pure anti-HLA-DQ (SPVL3, mIgG2a) and
phycoerythrin-conjugated anti-T cell receptor (TCR) a/b (BMA031,
IgG2b) were obtained from Immunotech (Marseille, France). FITC-
conjugated control mouse Ig was from BD PharMingen.
Nickel-speci®c T cell lines and clones Short-term nickel-speci®c
CD4+ T cell lines were obtained from the peripheral blood of nickel-
allergic patients, as previously described (Cavani et al, 2000). Brie¯y,
peripheral blood mononuclear cells (PBMC) were separated by
centrifugation over Ficoll-Hypaque (Lymphoprep, Nycomed-Pharmacia,
Oslo, Norway) and left to adhere (6 3 106 cells per ml) in Petri dishes
for 2 h at 37°C with 5% CO2 in RPMI 1640 complemented with
2 mM glutamine, 1 mM sodium pyruvate, 1% nonessential amino acids,
0.05 mM 2-mercaptoethanol, 100 U per ml penicillin, and 100 mg per
ml streptomycin (all from Invitrogen Italia, San Giuliano Milanese, Italy)
(complete RPMI) and 5% autologous plasma. CD4+ T lymphocytes
were positively selected from the nonadherent fraction by incubation
with immunomagnetic beads coated with speci®c MoAb (Dynabeads
M450, Dynal, Oslo, Norway). Blood-derived T cell lines were cloned
by limiting dilution (0.5 cells per well in 96-well U-bottomed
microplates) in complete RPMI plus 10% fetal bovine serum (FBS;
Hyclone, Logan, UT) in the presence of 3 3 105 allogeneic feeder cells,
1% phytohemagglutinin (Life Technologies), and 30 U per ml
recombinant human interleukin-2 (IL-2) (kindly provided by Chiron
Italia). T cell clones were grown with IL-2 and stimulated monthly with
1% phytohemagglutinin and feeder cells or with plate-coated anti-CD3
plus soluble anti-CD28 (both at 0.5 mg per ml). Antigen speci®city of T
cell clones was assessed using irradiated PBMC or autologous Epstein±
Barr virus (EBV) transformed B cell lines with or without 10 mg per ml
NiSO4 (Sigma-Aldrich, Milan, Italy) in complete RPMI supplemented
with 5% autologous plasma. After 32 h, cocultures were pulsed with
5 mCi per ml 3[H]thymidine (Amersham, Little Chalfont, U.K.) for 16 h
at 37°C, and then harvested onto ®ber-coated 96-well plates (Packard
Instruments, Groningen, The Netherlands). Radioactivity was measured
in a beta counter (Packard Instruments).
Preparation of monocyte-derived DC and B cell lines Adherent
PBMC were depleted of CD2+, CD19+, and CD56+ cells by negative
selection with MoAb-coated immunomagnetic beads (Dynal). The
resulting population (>90% CD14+ cells) was cultured in complete
RPMI supplemented with 10% FBS, 200 ng per ml rhGM-CSF
(Mielogen, Schering-Plough, Milan, Italy), and 200 U per ml rhIL-4
(R&D Systems, Minneapolis, MN) at 37°C with 5% CO2 for 6±7 d.
Lipopolysaccharide from Escherichia coli (Sigma) was added at 50 mg per
ml for the last 24 h of culture. This procedure gave >95% pure CD1a+
CD14± CD83+ mature DC preparations. Autologous B cell lines were
generated by incubating PBMC with supernatant from the EBV-
producing marmoset line B95/8 (American Type Culture Collection,
Rockville, MD) in the presence of 2 mg per ml cyclosporine A for 7±
15 d.
Flow cytometry analysis Resting and activated CD4+ T cell clones
were washed in phosphate-buffered saline with 2% FBS and 0.01%
NaN3, and then stained with FITC- or phycoerythrin-conjugated
MoAb. Staining with matched isotype control Ig was included. Cells
were analyzed with a FACScan equipped with Cell Quest software
(Becton Dickinson, Mountain View, CA). The kinetics of TCR
downregulation was evaluated in the presence or the absence of
professional APC and 10 mg per ml NiSO4. Cells were cultured at 37°C
with 5% CO2, and at selected time points they were collected, ®xed
with 2% paraformaldheyde (PFA) for 15 min on ice, and stained with
anti-TCR MoAb.
Antigen presentation assays DC (5000 cells per well) or EBV-
transformed B cells (50,000 cells per well) were cocultured with
autologous T cells (50,000 cells per well) in ¯at-bottomed 96-well plates
with or without NiSO4. Alternatively, T cells were incubated with or
without NiSO4 in the absence of DC or B cells. In selected experiments,
DC, B cells or T cells were pulsed with 20 mg per ml NiSO4 for 2 h at
37°C, washed with complete RPMI with 20% FBS, and then used to
stimulate responding T lymphocytes. In blocking experiments, APC
were incubated with 1 mg per ml of MoAb or control IgG for 30 min
on ice followed by 30 min at 37°C before the addition of NiSO4. To
de®ne the requirement of antigen processing, B cells were ®xed with 2%
PFA for 10 min at room temperature, resuspended in 0.15 M glycine for
1 min, and ®nally washed twice before use. Fixation was performed
either before or after pulsing with NiSO4. Incorporation of
3[H]thymidine was measured 12±96 h after stimulation. Cultures were
carried out in triplicate for each condition.
T cell cytokine release Supernatants from T cell clones (106 cells per
ml) stimulated in 24-well plates with or without autologous DC or
EBV-transformed B cells in the presence of 10 mg per ml NiSO4 were
collected after 12±96 h culture, ®ltered, and stored at ±80°C. IL-4, IL-
10, and interferon-g (IFN-g) content was measured by enzyme-linked
immunosorbent assay (ELISA; Duoset Elisa System Kit, R&D Systems)
following the manufacturer's instructions. Cultures were carried out in
triplicate for each condition.
T cell anergy assay T cells were stimulated with or without DC in
the presence or the absence of NiSO4 (®rst stimulation). After 24 h of
coculture, cells were collected, washed extensively, and plated in 24
wells with low dose IL-2 (10 U per ml) to maintain cell viability
(Barnaba et al, 1994; Steinbrink et al, 1997). After 8 d, T cells (50,000
per well) were transferred in 96-well plates with DC (5000 per well) in
the presence or not of NiSO4 (second stimulation). T cell proliferation
was evaluated after the ®rst and second stimulation as described above.
RESULTS
A subset of nickel-speci®c T cells activates in the absence of
professional APC Nickel-speci®c T cell clones were generated
from the peripheral blood of six allergic subjects and characterized
for their antigen speci®city and cytokine expression pro®le. To
determine their APC requirement, proliferation to nickel was
assessed in the presence or the absence of autologous EBV-
transformed B cells. To avoid contamination with other cell
populations, T cell clones were expanded with plate-bound anti-
CD3 plus soluble anti-CD28 MoAb in the absence of feeder cells.
Moreover, carry-over of contaminating monocytes, DC, or B cells
was excluded by ¯uorescence-activated cell sorter analysis, which
demonstrated the absence of CD14+, CD19+, or CD1a+ cells in
the T cell cultures. All the clones proliferated in vitro in the presence
of autologous B cells and 10 mg per ml NiSO4. A signi®cant
number of these clones, however, could be activated by nickel in
the absence of professional APC (APC-independent clones),
suggesting a direct T±T hapten presentation. In contrast, the
activation of the remaining clones strictly depended on the
presence of professional APC (APC-dependent clones). Table I
shows the results from one patient, whereas Table II summarizes
the results on 121 clones obtained from the six subjects studied.
The frequency of APC-independent clones ranged from 30% to
47% (average 35%). Both the APC-dependent and APC-
independent clones showed a predominant T helper (Th) 1
cytokine pro®le, with high release of IFN-g. Less than 10% of both
clone types was Th0. On the other hand, among APC-independent
clones a higher percentage of Th2 was detected (14.2% vs 7.6%). In
contrast, T regulatory (Tr) lymphocytes, characterized by high IL-
10 production and a potent immunosuppressive activity (Cavani
et al, 2000; Sebastiani et al, 2001), were less represented among the
APC-independent clones (11.9% vs 21.5%).
T±T nickel presentation is MHC class II restricted, un-
in¯uenced by CD28 triggering, and occurs independently
from the state of activation of the T cells To better
understand the mechanisms of T±T nickel presentation, blocking
experiments were performed with speci®c anti-MHC class II,
-CD80, or -CD86 MoAb. T cell proliferation was strongly
inhibited by anti-HLA-DR in all but two T clones, which were
blocked instead by anti-HLA-DQ MoAb (Fig 1A, B). In contrast,
anti-CD80 or anti-CD86 pretreatment did not signi®cantly affect T
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cell responses. It has been shown that the capacity of T cells to
present nominal antigens is heavily in¯uenced by their activation
state, which affects the endocytic capacity and the neo-synthesis of
MHC class II molecules (Barnaba et al, 1994). Thus, we compared
resting (2 wk after anti-CD3/CD28 stimulation; CD25 negative)
and activated (6 d after anti-CD3/CD28 stimulation, CD25
positive) APC-independent and APC-dependent clones in their
ability to respond to nickel in the absence of professional APC.
Both resting and activated APC-independent clones proliferated to
nickel, although activated clones responded earlier and less potently
than resting clones (Fig 1C). In contrast, neither activated nor
resting APC-dependent clones proliferated to nickel in the absence
of professional APC.
APC-independent T cells show a distinct antigen recogni-
tion capacity We next investigated whether the unique
behavior of APC-independent clones was due to distinct antigen-
presenting or antigen recognition capacities. Resting, CD25
negative, APC-independent T cell clones showed a high
expression of MHC class II molecules and variable (moderate to
high) expression of the costimulatory molecules CD80 and CD86,
which were strongly upregulated upon TCR triggering with anti-
Table I. A portion of nickel-speci®c T cell clones from the peripheral blood of a nickel-allergic patient proliferates in the
absence of professional APCa
T cell clone
APC + T
cells + NiSO4
APC +
T cells
T cells +
NiSO4 T cells
IFN-gb
(ng per ml)
IL-4b
(ng per ml)
IL-10b
(ng per ml)
FN4.1.2 11.46 1.53 0.34 0.24 2.1 0.1 2.2
FN4.1.3 3.88 0.97 0.28 0.35 2.2 0 0
FN4.1.4 3.48 1.00 0.84 0.63 0.4 0 5.3
FN4.1.5 4.27 1.10 0.37 0.47 0.8 0 6.4
FN4.1.6 3.71 0.73 0.34 0.58 0.5 0 6.1
FN4.1.8 3.99 1.05 0.52 0.45 0.6 0 2.3
FN4.1.9 3.12 1.29 0.24 0.24 0 0.1 2.4
FN4.1.11 43.33 1.29 31.45 0.51 6.1 0 1.5
FN4.1.12 33.43 1.15 30.41 0.53 7.1 0.1 2.9
FN4.1.13 51.18 1.98 35.78 0.38 6.4 0.1 2.6
FN4.1.14 15.27 0.93 0.13 0.27 2.5 0.2 0.1
FN4.1.15 12.19 0.96 0.09 0.16 4.2 1.7 1
FN4.1.17 15.69 0.72 0.08 0.17 3.8 0.2 1.7
FN4.1.18 3.01 0.63 3.28 0.43 0.2 0.1 3.8
FN4.1.19 48.86 2.07 31.11 0.50 0 0 2.9
FN4.1.20 40.60 1.88 26.31 0.47 0.2 1.7 3
FN4.1.22 21.03 0.99 0.81 0.19 0.8 0 4.3
FN4.1.23 38.17 0.71 11.43 0.28 3 0 0.2
FN4.1.24 9.150 1.05 6.43 0.40 2.9 8.9 8.5
FN4.1.25 30.98 2.28 0.24 0.23 0.2 0 0.6
FN4.1.34 10.83 0.70 0.22 0.03 0.1 0.4 0
FN4.1.43 26.18 1.86 0.19 0.07 2.5 0 1.4
FN4.1.48 29.75 2.18 0.05 0.04 2.9 0.2 2.6
FN4.1.59 27.22 1.28 0.41 0.29 4.9 0 2.7
FN4.1.64 20.88 0.36 0.22 0.26 1 0 7.2
FN4.1.66 44.38 0.98 31.99 0.43 6.7 0 2.6
FN4.1.67 49.78 1.83 12.97 0.17 4.2 0 0.7
aT cells were stimulated in the presence or absence of EBV-transformed B cells and/or 10 mg per ml NiSO4. 3[H]thymidine uptake was measured after 48 h of culture.
Results are given as mean cpm 3103 of triplicate cultures.
bCytokine release was evaluated by ELISA on supernatants of triplicate cultures stimulated 48 h with B cells plus nickel. SD were < 15% of mean values, and have been
omitted for simplicity.
Table II. About one-third of nickel-speci®c T cell clones are APC independent, and show a predominant Th1 cytokine
expression pro®le
Subject T cell clone type Number (%) Th1 No (%) Th0 No (%) Th2 No (%) Tr No (%)
AL APC dependent 8 (53) 3 (37.5) 1 (12.5) 3 (37.5) 1 (12.5)
APC independent 7 (47) 2 (28.5) 1 (14.2) 4 (57.1) 0
FN APC dependent 17 (63) 7 (41.1) 1 (5.8) 1 (5.8) 8 (47)
APC independent 10 (37) 6 (60) 1 (10) 1 (10) 2 (20)
LC APC dependent 7 (70) 6 (85.7) 0 0 1 (14.3)
APC independent 3 (30) 2 (66.6) 0 1 (33.3) 0
GC APC dependent 20 (66) 18 (90) 2 (10) 0 0
APC independent 10 (33) 9 (90) 1 (10) 0 0
KK APC dependent 6 (66) 2 (33.3) 0 (16.6) 1 3 (50)
APC independent 3 (33) 1 (33.3) 1 (33.3) 0 1 (33.3)
AC APC dependent 21 (70) 14 (66.6) 2 (9.5) 1 (4.7) 4 (19)
APC independent 9 (30) 7 (77.7) 0 0 2 (22.3)
Total APC dependent 79 (65) 50 (63.3) 6 (7.6) 6 (7.6) 17 (21.5)
APC independent 42 (35) 27 (64.2) 4 (9.5) 6 (14.2) 5 (11.9)
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CD3 MoAb (Fig 2). The levels of MHC class II and costimulatory
molecules did not differ signi®cantly from those present on APC-
dependent clones, both in resting and activated state. To further
sustain the hypothesis that T±T nickel presentation was not
associated with increased antigen-presenting functions of the T
cells, cross-experiments were performed using nickel-pulsed APC-
independent or APC-dependent T cells as APC and responding T
cells. Irradiated APC-dependent or APC-independent T cell clones
pulsed with NiSO4 were equally capable of stimulating APC-
independent, but not APC-dependent T cells (Fig 3). These
®ndings demonstrated that T±T nickel activation was not due to a
particular antigen-presenting function of APC-independent clones,
but rather was correlated with a distinct antigen recognition
capacity.
As peptides but not complex proteins can be presented by T cells
(Gerrard et al, 1985; Hewitt et al, 1989; LaSalle et al, 1991) in the
next set of experiments we evaluated whether antigen processing
was required for nickel-speci®c T cell activation. To address this
issue, B cells were ®xed with 2% PFA either after (pulsed/®xed
APC) or prior to (®xed/pulsed APC) pulsing for 2 h with 20 mg
per ml NiSO4, and ®nally were used as stimulators for T cell clones.
All the 30 APC-independent T cell clones responded to the antigen
when presented by pulsed/®xed APC or ®xed/pulsed APC,
indicating that processing was not necessary for proper T cell
recognition. In contrast, a more variable behavior was observed
among APC-dependent T cells, with some (17 of 30) responding to
both pulsed/®xed and ®xed/pulsed APC, and others (13 of 30)
responding only to pulsed/®xed APC (Fig 4). These results
indicated that the APC-independent T cell clones recognized
only nickel epitopes not requiring processing. Not all the T cell
clones that recognized a processing-independent nickel epitope
could be activated through a direct T±T presentation of the metal,
however.
T±T hapten presentation results in IFN-g release, TCR
downregulation, CD25, CD80, and CD86 upregulation,
and is not followed by T cell anergy The fate of T cells after
T±T antigen presentation has been previously investigated with
Figure 1. T±T nickel presentation is MHC class II restricted,
unin¯uenced by CD28 triggering, and occurs independently of
the state of activation of T cells. The APC-independent T cell clones
FN4.1.12 (A) and AC4.1.7 (B) were preincubated 30 min on ice with
the indicated MoAb and then directly stimulated with 10 mg per ml
NiSO4. The ®gure shows the results obtained with two representative
clones out of 65 examined. (C) APC-independent (clone AC4.1.7,
squares) and APC-dependent (clone AC4.1.19, diamonds) clones either
resting (2 wk after stimulation, open symbols) or activated (6 d after
stimulation, ®lled symbols) were compared in their nickel-speci®c response
in the absence of added APC. Results are expressed as mean cpm 6 SD
of triplicate cultures.
Figure 2. APC-dependent and APC-independent T cell clones
express comparable levels of MHC class II and costimulatory
molecules both in the resting state and upon activation. APC-
dependent (FN4.1.3, FN4.1.15) and APC-independent (FN4.1.23,
FN4.1.66) clones were stained with speci®c MoAb or control Ig (dotted
histograms) both in the resting condition (continuous thin histograms) or
48 h after anti-CD3 activation (continuous bold lines), and examined by
¯ow cytometry. Left and right numbers represent the net mean
¯uorescence intensity of resting and activated T cells, respectively.
Results are representative of 55 T cell clones examined.
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controversial results (Lamb et al, 1983; Celis et al, 1992; Sidhu et al,
1992; Barnaba et al, 1994; Marelli-Berg et al, 1997; Taams et al,
1999). T±T nickel presentation was followed by cell proliferation
and IFN-g release comparable to those induced by B-cell±T
presentation. DC±T presentation resulted in signi®cantly higher
cell proliferation and IFN-g secretion, and required a lower nickel
concentration for optimal T cell activation (Fig 5A, B). These
differences were not the consequence of a diverse kinetics of the T
cell response as in both T±T and DC±T nickel presentation
maximal response was achieved after 48 h of coculture (data not
shown). Antigen recognition determines a rapid internalization of
the CD3±TCR complex, which is proportional to the degree of
TCR stimulation induced by peptide±MHC complexes (Valitutti
et al, 1995). T±T nickel presentation induced a rapid TCR±CD3
downregulation in APC-independent, but not APC-dependent, T
cells, reaching a plateau at 6 h after addition of nickel (Fig 5C).
TCR downregulation, as well as upregulation of CD25, HLA-DR,
CD80, and CD86 (Fig 5D), induced by T±T presentation was less
prominent, however, than those determined by DC±T
presentation, and, in the case of TCR downregulation, also
slightly delayed in time. All these ®ndings con®rmed that T±T
nickel presentation led to a functional T cell activation, although
less conspicuous than that induced by professional APC.
Finally we tested whether T±T presentation in APC-independ-
ent cells was followed by anergy. After the ®rst stimulation, T cell
clones were maintained in culture with minimal IL-2 concentration
(10 U per ml) for 8 d, and then further assayed in their capacity to
respond to the hapten in the presence or absence of DC. Results
indicated that T cells previously activated through either a T±T or a
DC±T nickel presentation maintained a comparable attitude to
proliferation in response to DC and nickel (Fig 6), suggesting that
T±T presentation did not result in T cell anergy.
DISCUSSION
Recently activated T lymphocytes express MHC class II and
functional B7 molecules both in vivo and in vitro (Azuma et al, 1993;
Barnaba et al, 1994; Hollsberg et al, 1997; Jeannin et al, 1999), and
may thus potentially act as APC for memory/effector T cells
engaged in peripheral immune responses. Our work provides
evidence that a signi®cant number of nickel-speci®c T cells isolated
from allergic subjects can be directly activated by the metal in the
absence of professional APC. T±T nickel presentation was MHC
Figure 3. APC-independent T cell clones proliferate to both
nickel-pulsed APC-independent and APC-dependent T cells.
APC-independent (AC4.1.63) or APC-dependent (AC4.1.41) T cells
were used either as stimulator or responding cells in cross-experiments.
Mature DC were used as control APC. Stimulator T cells were pulsed
2 h with 20 mg per ml NiSO4, washed, and irradiated before use. Data
are expressed as mean cpm 6 SD of triplicate cultures. Results are
representative of experiments performed with six T cell clones of both
groups.
Figure 4. T±T nickel presentation does not require processing.
EBV-transformed B cells were either pulsed for 2 h with 20 mg per ml,
washed, and then ®xed in 2% PFA (pulsed/®xed APC) or ®xed before
the pulsing procedure (®xed/pulsed APC). B cells were irradiated and
used as stimulators in antigen presentation assays with either APC-
independent (A) or APC-dependent (B) T cell clones. Data are expressed
as mean cpm 6 SD of triplicate cultures. Results of six T cell clones of
each group out of 30 examined are shown.
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class II restricted, independent from CD28 triggering, and was
followed by CD25, CD80, CD86 upregulation, cytokine release,
and cell proliferation. Indeed, a common immunohistochemical
®nding of ACD is the presence of a relevant number of HLA-DR+
T lymphocytes (Ralfkiaer and Wantzin, 1984). HLA-DR expressed
by T lymphocytes can derive from neo-synthesis or absorption of
cell surface MHC±peptide complexes from the APC membrane
during APC±T cell interactions (Arnold et al, 1997; Huang et al,
1999; Hwang et al, 2000). It has been previously shown that T cells
may present peptides and denatured protein antigens. Resting T
lymphocytes have a limited endocytic capacity, however, and are
relatively inef®cient in processing soluble proteins in the absence of
speci®c membrane receptors (Hewitt and Feldman, 1989; LaSalle
et al, 1991; Franco et al, 1992). T cell activation encompasses both
augmented liquid phase pynocytosis and MHC class II synthesis,
allowing T lymphocytes to internalize and process complex
proteins (Barnaba et al, 1994). In the case of nominal antigens,
differences among T lymphocytes concerning their capacity to
respond to a T±T antigen presentation have not been described.
Our data indicate that only a subset of nickel-speci®c T
lymphocytes respond to the hapten in the absence of professional
APC. This unique attribute of APC-independent T cells to be
activated following T±T presentation does not depend upon an
enhanced antigen-presenting capability. In fact, APC-independent
and APC-dependent T cell clones expressed comparable levels of
MHC class II molecules both in resting and activated states.
Additionally, APC-dependent and APC-independent clones pulsed
with nickel were equally ef®cient in promoting activation of APC-
independent T cells, but they were both incapable of stimulating
APC-dependent T cell clones in cross-experiments. The degree of
T cell activation did not signi®cantly affect T±T nickel presentation
in either APC-independent or APC-dependent clones, and the
latter were unresponsive to nickel at any state of activation when
stimulated in the absence of professional APC. These ®ndings
indicate that the epitope recognized by APC-independent T cells
may be generated and exposed on the surface of both T cell types,
whereas APC-dependent T cells recognize one or more epitopes
generated only by professional APC. In addition, APC-independ-
ent T cells stimulated by professional APC and nickel showed a
higher proliferation compared to APC-dependent clones. In these
conditions, the selective block of MHC class II on APC-
independent T cells prior to culture with professional APC
Figure 5. T±T presentation is less effective in
promoting proliferation, IFN-g release, TCR
downregulation, and upregulation of CD25,
CD80, CD86, and MHC class II compared to
DC-T presentation. (A) DC or B cells were
incubated with grading doses of NiSO4, irradiated,
and used to stimulate the APC-independent T cell
clone AC4.1.70. Alternatively, NiSO4 was added
directly to AC4.1.70 culture. Proliferation was
evaluated by adding 3[H]thymidine for the last
12 h of coculture. Data are expressed as mean
cpm 6 SD of triplicate cultures. (B) Supernatants
were collected at 12±96 h of DC±T and T±T
cocultures and evaluated for IFN-g content by
ELISA. Data are expressed as mean 6 SD pg per
ml of triplicate cultures. (C) To evaluate TCR
downregulation in responding T cells, DC±T cell
cocultures or T cells alone were incubated with
10 mg per ml NiSO4 at 37°C and at serial time
points cells were ®xed with PFA 2%, stained with
anti-TCR MoAb, and examined by ¯ow
cytometry. Results are given as the net mean
¯uorescence intensity. (D) The APC-independent
T cell clone AC4.1.2 was activated with 10 mg
per ml of NiSO4 with or without autologous DC.
At day 0 or after 48 h, T cells were collected,
stained with the speci®c MoAb, and evaluated by
¯ow cytometry gating CD3 positive cells. Data
are given as mean ¯uorescence intensity at day 0
(continuous histograms and normal characters) and at
48 h (bold histograms and characters) subtracted from
the isotype control (dotted histograms).
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reduced T cell proliferation by 30%±35% (data not shown). This
®nding suggests that APC-independent T cells can recognize
hapten±class II complexes on both T cells themselves and
professional APC.
Haptens are visible to the immune system as hapten±peptide
complexes bound to MHC molecules (Martin et al, 1993; Cavani
et al, 1995). Metals behave as haptens in many respects, and nickel
can directly interact with peptides in the groove of MHC class II
molecules forming square-planar structures frequently involving
histidine residues (Sinigaglia, 1994). Both nickel and urushiol
interaction with APC give rise to processing-independent and
processing-dependent epitopes, the latter deriving from internaliz-
ation of hapten molecules or hapten±protein complexes (Kalish etal,
1994; Moulon et al, 1995). Moreover, the existence of distinct
populations of nickel-speci®c T cells differing in their APC
requirements has been suggested by previous work. In particular,
some T cell clones have been reported to be activated by both DC
and B cells, and others exclusively activated by skin-derived DC
(Kapsenberg et al, 1987). Finally, it has been shown that a
signi®cant portion of nickel-speci®c T cell clones proliferated in
the continuous presence of the metal but were unresponsive when
stimulated by nickel-pulsed APC (Moulon et al, 1995). To better
understand the nature of the epitopes recognized by APC-
independent T cell clones, we performed experiments with PFA-
®xed APC. The results demonstrate that the epitopes recognized by
APC-independent T cell clones do not require processing. Thus, in
T±T presentation the epitopes were generated by a direct
interaction of the hapten with MHC class II molecules expressed
on T cells, in agreement with the data previously described for
nominal antigens. Nevertheless, not all the processing-independent
clones belonged to the APC-independent subtype, suggesting that
independence from APC processing was necessary but not
suf®cient for T±T presentation. It is reasonable to hypothesize
that fewer epitopes are generated by T cells upon interaction with
nickel, whereas professional APC may display a broader spectrum
of nickel epitopes.
The role of T±T hapten presentation in the expression of
peripheral immune responses may vary depending on the outcome
of the T cell activation. It has been recently reported that T cell
self-presentation determines a more sustained and prolonged TCR
downregulation compared to that induced by APC±T cell
presentation, fails to upregulate OX40 and B7, and leads ultimately
to a state of T cell unresponsiveness (Taams et al, 1999). Thus, T±T
presentation has been proposed as an ef®cient regulatory mechan-
ism involved in the maintenance of peripheral T cell tolerance
(Lamb et al, 1983; Celis et al, 1992; Sidhu et al, 1992; Marelli-Berg
et al, 1997; Taams et al, 1998). Other reports did not reveal any
difference in the quality of the T cell activation after T±T antigen
presentation, however, and did not show induction of anergy
(Barnaba et al, 1994). T±T nickel presentation in our APC-
independent T cell subset induced TCR downregulation, CD80,
CD86, HLA-DR, and CD25 upregulation, as well as IFN-g release
and cell proliferation, indicating a full-competent activation of the
T cells, although these modi®cations were quantitatively more
limited than those induced by mature DC. Importantly, following
T±T nickel activation, APC-independent T cells maintained their
capacity to respond to the metal both in a T±T- and in an APC±T-
dependent manner, indicating that although T±T nickel presenta-
tion induced a lower grade of T cell activation, it was not followed
by induction of T cell anergy. Nickel-speci®c Th cells are very
heterogeneous with respect to their cytokine expression pro®le,
with Th1 playing a predominant effector role and Tr cells exerting
primarily a regulatory activity by inhibiting DC maturation and
functions (Cavani et al, 2001). APC-independent clones secreted
large amounts of IFN-g and were predominantly Th1, similar to
the APC-dependent clones. On the other hand, a higher and lower
percentage of Th2 and Tr clones, respectively, was detected among
APC-independent T cells. Although this result is potentially very
interesting, it deserves further con®rmation on a larger series of
clones. The fact that APC-dependent T cells are less polarized
towards the Tr cell subset may suggest that they are mainly
involved in effector/in¯ammatory activities.
In conclusion, our data suggest that, in the efferent phase of
ACD, T lymphocytes can simultaneously act as effector cells and
APC. In particular, the subset of APC-independent lymphocytes
could have a role in the initiation and rapid ampli®cation of the
skin allergic reaction, representing a ready-to-go subset of nickel-
reactive T cells not requiring professional APC for complete
functional activation.
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